Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 17, 2009 - Issue 6
Submit an article Journal homepage
365
Views
56
CrossRef citations to date
0
Altmetric
Original Article

Clinical Review: Anti-TNFα Therapies in Uveitis: Perspective on 5 Years of Clinical Experience

Srilakshmi M. SharmaAcademic Unit of Ophthalmology, Bristol Eye Hospital, Bristol, UK
, MBChB, MRCP, MRCOphth,
Achim R. NestelAcademic Unit of Ophthalmology, Bristol Eye Hospital, Bristol, UK
, PhD,
Richard W. J. LeeAcademic Unit of Ophthalmology, Bristol Eye Hospital, Bristol, UK
, PhD, MRCOphth &
Andrew D. DickAcademic Unit of Ophthalmology, Bristol Eye Hospital, Bristol, UKCorrespondence[email protected]
, MD, FRCP, FRCOphth, FMed Sci
Pages 403-414 | Received 24 Apr 2009, Accepted 14 May 2009, Published online: 09 Dec 2009

Citations (56)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (12)

Ruchika Lakra, Amravi Shah, Viswanath Kaushik, Jyotirmay Biswas & Parthopratim Dutta Majumder. (2021) Use of Anti-Tumour Necrosis Factor-Alpha Agents in the Management of HLA-B-27-Associated Uveitis: The First Case Series from India. Ocular Immunology and Inflammation 29:2, pages 232-236.
Read now
Horace Massa, Spyros Y Pipis, Temilade Adewoyin, Athanasios Vergados, Sudeshna Patra & Georgios D Panos. (2019) Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges. Clinical Ophthalmology 13, pages 1761-1777.
Read now
Sumita Phatak, Rupesh Agrawal & Carlos Pavesio. (2014) Adalimumab: viable treatment option for pediatric refractory uveitis?. Expert Review of Ophthalmology 9:3, pages 175-184.
Read now
Alfredo Adán, Marina Mesquida & Victor Llorenç. (2013) Biologic drugs in noninfectious uveitis: an update. Expert Review of Ophthalmology 8:5, pages 501-516.
Read now
Miguel Cordero-Coma, Sara Calleja, Milagros Llorente, Esther Rodriguez, Manuel Franco & Jose G. Ruiz de Morales. (2013) Serum Cytokine Profile in Adalimumab-treated Refractory Uveitis Patients: Decreased IL-22 Correlates with Clinical Responses. Ocular Immunology and Inflammation 21:3, pages 212-219.
Read now
S. Eperon, K. Balaskas, J. Vaudaux & Y. Guex-Crosier. (2013) Experimental Uveitis can be Maintained in Rabbits for a Period of Six Weeks After a Safe Sensitization Method. Current Eye Research 38:3, pages 405-412.
Read now
C. J. Chu, S. E. Barker, A. D. Dick & R. R. Ali. (2012) Gene Therapy for Noninfectious Uveitis. Ocular Immunology and Inflammation 20:6, pages 394-405.
Read now
Emmett T. Cunningham$suffix/text()$suffix/text(), Debra A. Goldstein & Manfred Zierhut. (2012) Uveitis Treatment Trials—A Cross-study Perspective. Ocular Immunology and Inflammation 20:2, pages 63-67.
Read now
Emmett T. Cunningham$suffix/text()$suffix/text(), Sirichai Pasadhika, Eric B. Suhler & Manfred Zierhut. (2012) Drug-induced Inflammation in Patients on TNFα Inhibitors. Ocular Immunology and Inflammation 20:1, pages 2-5.
Read now
Aurore Muselier, Philip Bielefeld, Samuel Bidot, Julien Vinit, Jean-François Besancenot & Alain Bron. (2011) Efficacy of Tocilizumab in Two Patients with anti-TNF-alpha Refractory Uveitis. Ocular Immunology and Inflammation 19:5, pages 382-383.
Read now
Annette Ossewaarde-van Norel & Aniki Rothova. (2011) Clinical Review: Update on Treatment of Inflammatory Macular Edema. Ocular Immunology and Inflammation 19:1, pages 75-83.
Read now
Emmett T. Cunningham$suffix/text()$suffix/text() & Manfred Zierhut. (2010) TNF Inhibitors for Uveitis: Balancing Efficacy and Safety. Ocular Immunology and Inflammation 18:6, pages 421-423.
Read now

Articles from other publishers (44)

Mi Zhang & Xiaomin Zhang. (2023) T cells in ocular autoimmune uveitis: Pathways and therapeutic approaches. International Immunopharmacology 114, pages 109565.
Crossref
Laura E.M. Eurelings, Tom O.A.R. Missotten, Mirjam E.J. van Velthoven, Paul L.A. van Daele, Jan A.M. van Laar, P. Martin van Hagen, Alberta A.H.J. Thiadens & Saskia M. Rombach. (2022) Long-Term Follow-up of Patients With Uveitis Treated With Adalimumab: Response Rates and Reasons for Discontinuation of Therapy. American Journal of Ophthalmology 240, pages 194-204.
Crossref
Theodore A. Pasquali, Melissa M. Toyos, David B. Abrams, David K. Scales, John W. SeamanIIIIII & Georges Weissgerber. (2022) Topical Ocular Anti-TNFα Agent Licaminlimab in the Treatment of Acute Anterior Uveitis: A Randomized Phase II Pilot Study. Translational Vision Science & Technology 11:6, pages 14.
Crossref
Mohammad Refaat, Abdussalam M. Abdullatif, Mostafa M. Hamza, Tamer A. Macky, Mohamed-Sameh H. El-Agha, Gaafar RagabMahmoud M. Soliman. (2021) MONTHLY INTRAVITREAL INFLIXIMAB IN BEHÇET'S DISEASE ACTIVE POSTERIOR UVEITIS. Retina 41:8, pages 1739-1747.
Crossref
Lei Zhu, Binyao Chen & Wenru Su. (2021) A Review of the Various Roles and Participation Levels of B-Cells in Non-Infectious Uveitis. Frontiers in Immunology 12.
Crossref
Mathilde Leclercq, Anne-Claire Desbois, Fanny Domont, Georgina Maalouf, Sara Touhami, Patrice Cacoub, Bahram Bodaghi & David Saadoun. (2020) Biotherapies in Uveitis. Journal of Clinical Medicine 9:11, pages 3599.
Crossref
Adam V Weizman, Geoffrey C Nguyen, Cynthia H Seow, Laura Targownik, Sanjay K Murthy, Karen Boland, Nooran M Afzal, Reena Khanna, Jennifer Jones, Waqqas Afif, Smita Halder, Jason Reinglas, Sharyle Fowler, Vivian Huang, Gilaad G Kaplan & Gil Y Melmed. (2019) Appropriateness of Biologics in the Management of Crohn’s Disease Using RAND/UCLA Appropriateness Methodology. Inflammatory Bowel Diseases 25:2, pages 328-335.
Crossref
Riccardo Sacconi, Chiara Giuffrè, Eleonora Corbelli, Enrico Borrelli, Giuseppe Querques & Francesco Bandello. (2019) Emerging therapies in the management of macular edema: a review. F1000Research 8, pages 1413.
Crossref
Robert J Barry, Mohammad O Tallouzi, Nick Bucknall, Jonathan M Mathers, Philip I Murray, Melanie J Calvert, David J Moore & Alastair K Denniston. (2018) Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitis. Cochrane Database of Systematic Reviews 2018:12.
Crossref
Ester Carreño, Alejandro Portero, José M. Herreras, Carmen García‐Vázquez, Scott M. Whitcup, Michael E. Stern, Margarita Calonge & Amalia Enríquez‐de‐Salamanca. (2016) Cytokine and chemokine tear levels in patients with uveitis. Acta Ophthalmologica 95:5.
Crossref
Mohammad O Tallouzi, Robert J Barry, Nick Bucknall, Jonathan M Mathers, Philip I Murray, Melanie J Calvert, David J Moore & Alastair K Denniston. (2017) Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitis. Cochrane Database of Systematic Reviews.
Crossref
Izabela P. Klaska, Elizabeth Muckersie, Cristina Martin‐Granados, Maria Christofi & John V. Forrester. (2016) Lipopolysaccharide‐primed heterotolerant dendritic cells suppress experimental autoimmune uveoretinitis by multiple mechanisms. Immunology 150:3, pages 364-377.
Crossref
A D Dick. (2016) Doyne lecture 2016: intraocular health and the many faces of inflammation. Eye 31:1, pages 87-96.
Crossref
Miguel Cordero-Coma, Sara Calleja-Antolín, Irene Garzo-García, Ana M. Nuñez-Garnés, Carolina Álvarez-Castro, Manuel Franco-Benito & Jose G. Ruiz de Morales. (2016) Adalimumab for Treatment of Noninfectious Uveitis. Ophthalmology 123:12, pages 2618-2625.
Crossref
C Fardeau, E Champion, N Massamba & P LeHoang. (2016) Uveitic macular edema. Eye 30:10, pages 1277-1292.
Crossref
Jens Klotsche, Martina Niewerth, Johannes-Peter Haas, Hans-Iko Huppertz, Angela Zink, Gerd Horneff & Kirsten Minden. (2016) Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA). Annals of the Rheumatic Diseases 75:5, pages 855-861.
Crossref
Raquel Goldhardt & Bradley Simon Rosen. (2016) Uveitic Macular Edema: Treatment Update. Current Ophthalmology Reports 4:1, pages 30-37.
Crossref
Svati Bansal, VeluchamyA Barathi, Daiju Iwata & Rupesh Agrawal. (2015) Experimental autoimmune uveitis and other animal models of uveitis: An update. Indian Journal of Ophthalmology 63:3, pages 211.
Crossref
Frank R. Brennan. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies 927 968 .
Richard W. Lee, Lindsay B. Nicholson, H. Nida Sen, Chi-Chao Chan, Lai Wei, Robert B. Nussenblatt & Andrew D. Dick. (2014) Autoimmune and autoinflammatory mechanisms in uveitis. Seminars in Immunopathology 36:5, pages 581-594.
Crossref
Marina Mesquida, Blanca Molins, Victor Llorenç, María Victoria Hernández, Gerard Espinosa, Andrew D. Dick & Alfredo Adán. (2013) Current and future treatments for Behçet’s uveitis: road to remission. International Ophthalmology 34:2, pages 365-381.
Crossref
Marina Mesquida, Blanca Molins, Victor Llorenç, Maite Sainz de la Maza, María Victoria Hernandez, Gerard Espinosa & Alfredo Adán. (2014) Proinflammatory Cytokines and C-Reactive Protein in Uveitis Associated with Behçet’s Disease. Mediators of Inflammation 2014, pages 1-8.
Crossref
Alastair K Denniston & Andrew D Dick. (2013) Systemic therapies for inflammatory eye disease: Past, Present and Future. BMC Ophthalmology 13:1.
Crossref
Imran J Khan, Robert J Barry, Kwesi N Amissah-Arthur, David Carruthers, Srinivasa Rao Elamanchi, Deva Situnayake, Philip I Murray, Alastair K Denniston & Saaeha Rauz. (2013) Ten-year experience of pulsed intravenous cyclophosphamide and methylprednisolone protocol (PICM protocol) in severe ocular inflammatory disease. British Journal of Ophthalmology 97:9, pages 1118-1122.
Crossref
John V. Forrester, Raymond J. Steptoe, Izabela P. Klaska, Cristina Martin-Granados, Harminder S. Dua, Mariapia A. Degli-Esposti & Matthew E. Wikstrom. (2013) Cell-based therapies for ocular inflammation. Progress in Retinal and Eye Research 35, pages 82-101.
Crossref
Alexandra Wexler, Trond Sand & Tor B Elsås. (2012) Bilateral macular thickening in mild unilateral anterior uveitis: is HLA-B27 involved?. BMC Ophthalmology 12:1.
Crossref
Paul M. TitchenellCheng-Mao LinJason M. KeilJeffrey M. SundstromCharles D. SmithDavid A. Antonetti. (2012) Novel atypical PKC inhibitors prevent vascular endothelial growth factor-induced blood–retinal barrier dysfunction. Biochemical Journal 446:3, pages 455-467.
Crossref
S Calleja, M Cordero-Coma, E Rodriguez, M Llorente, M Franco & J G Ruiz de Morales. (2012) Adalimumab specifically induces CD3+ CD4+ CD25high Foxp3+ CD127− T-regulatory cells and decreases vascular endothelial growth factor plasma levels in refractory immuno-mediated uveitis: a non-randomized pilot intervention study. Eye 26:3, pages 468-477.
Crossref
Andrew D. Dick. (2012) Road to Fulfilment: Taming the Immune Response to Restore Vision. Ophthalmic Research 48:1, pages 43-49.
Crossref
R W J Lee & A D Dick. (2011) Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation. Eye 26:1, pages 17-28.
Crossref
Alfredo Adán, Laura Pelegrín & Marina Mesquida. 2012. Tratamiento de la uveítis con fármacos anti-TNF-alfa. Tratamiento de la uveítis con fármacos anti-TNF-alfa 45 54 .
Alfredo Ad?n & Marina Mesquida. 2012. Tratamiento de la uve?tis con f?rmacos anti-TNF-alfa. Tratamiento de la uve?tis con f?rmacos anti-TNF-alfa 7 10 .
Antonia M. JoussenAntonia M. Joussen. 2012. Retinale Gefäßerkrankungen. Retinale Gefäßerkrankungen 335 398 .
Daniel Wendling, Julien Paccou, Jean-Marie Berthelot, René-Marc Flipo, Séverine Guillaume-Czitrom, Clément Prati, Emmanuelle Dernis, Guillaume Direz, Véronique Ferrazzi & Jean-Michel Ristori. (2011) New Onset of Uveitis During Anti-Tumor Necrosis Factor Treatment for Rheumatic Diseases. Seminars in Arthritis and Rheumatism 41:3, pages 503-510.
Crossref
Gillian M. Bell, Gary Reynolds & John D. Isaacs. (2011) Biologic therapies in non-rheumatic diseases: lessons for rheumatologists?. Nature Reviews Rheumatology 7:9, pages 507-516.
Crossref
Rizwan A. CheemaEssam Al-AskarHaider R. Cheema. (2011) Infliximab Therapy for Idiopathic Retinal Vasculitis, Aneurysm, and Neuroretinitis Syndrome. Journal of Ocular Pharmacology and Therapeutics 27:4, pages 407-410.
Crossref
Keith Wroblewski, H. Nida Sen, Steven Yeh, Lisa Faia, Zhuging Li, Pushpa Sran, Sapna Gangaputra, Susan Vitale, Patti Sherry & Robert Nussenblatt. (2011) Long-term daclizumab therapy for the treatment of noninfectious ocular inflammatory disease. Canadian Journal of Ophthalmology 46:4, pages 322-328.
Crossref
Ping Qiu, Michelle Kurpakus Wheater, Yue Qiu & Gabriel Sosne. (2011) Thymosin β 4 inhibits TNF‐α‐induced NF‐κB activation, IL‐8 expression, and the sensitizing effects by its partners PINCH‐1 and ILK . The FASEB Journal 25:6, pages 1815-1826.
Crossref
Carlos Jaime Velásquez Franco, Patricia Monsalve, Gloria Isabel Salazar Martínez, Ana Rivera, Liliana Zuluaga, Claudia Durán, Francisco Vargas, Aura Ligia Zapata-Castellanos & Oscar Jaír-Felipe Díaz. (2011) Uveítis y terapia anti-TNF. Revista Colombiana de Reumatología 18:1, pages 42-54.
Crossref
S. Winterhalter, P. Ruokonen, K.H. van der Velden, U. Pleyer & A.M. Joussen. (2011) Intravitreale ImplantateIntravitreal implants. Der Ophthalmologe 108:3, pages 222-229.
Crossref
Nihal Kenawy, Gavin Cleary, Devesh Mewar, Nicholas Beare, Arvind Chandna & Ian Pearce. (2010) Abatacept: a potential therapy in refractory cases of juvenile idiopathic arthritis-associated uveitis. Graefe's Archive for Clinical and Experimental Ophthalmology 249:2, pages 297-300.
Crossref
. (2010) Current World Literature. Current Opinion in Ophthalmology 21:6, pages 495-501.
Crossref
Tarnjit K. Khera, Andrew D. Dick & Lindsay B. Nicholson. (2010) Mechanisms of TNFα regulation in uveitis: Focus on RNA-binding proteins. Progress in Retinal and Eye Research 29:6, pages 610-621.
Crossref
Rachel R. Caspi. (2010) A look at autoimmunity and inflammation in the eye. Journal of Clinical Investigation 120:9, pages 3073-3083.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.